Thermo Fisher Scientific TMO Specialty Diagnostics — Selling, general and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses?
- Thermo Fisher Scientific (TMO) reported specialty diagnostics — selling, general and administrative expenses of $177M in Q1 2026.
- How has Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses changed year-over-year?
- Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses increased by 3.5% year-over-year, from $171M to $177M.
- What does specialty diagnostics — selling, general and administrative expenses mean?
- Operating expenses incurred by the Specialty Diagnostics segment for non-production activities, including sales force compensation, marketing, legal, and general corporate overhead. These costs support the segment's commercial operations and administrative infrastructure.